ERBB2 and breast carcinoma: The breast cancer cell lines T47D and MDA-MB-361 and the bladder cancer cell line RT112 were selected based on immunohistochemistry staining for HER2 on tumor xenografts using the HercepTestTM IHC kit (data not shown).